Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxypurinol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH known ✓ | P47989 | 7/20 | 1.00 |
| ▸ | TYMP | P19971 | 1/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | JAK1 | P23458 | 1/20 | 0.44 |
| ▸ | TYK2 | P29597 | 1/20 | 0.44 |
| ▸ | JAK3 | P52333 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxypurinol SCHEMBL9823223 | 0.98 | XDH (0.96) | XDHTYMPGSK3BBACE1JAK2 | |
| Oxypurinol SCHEMBL9003939 | 0.98 | XDH (0.96) | XDHTYMPGSK3BBACE1JAK2 | |
| Oxypurinol SCHEMBL9003927 | 0.98 | XDH (0.96) | XDHTYMPGSK3BBACE1JAK2 | |
| Oxypurinol SCHEMBL9003893 | 0.98 | XDH (0.96) | XDHTYMPGSK3BBACE1JAK2 | |
| Oxypurinol SCHEMBL9295181 | 0.96 | XDH (0.92) | XDHTYMPGSK3BBACE1JAK2 | |
| Oxypurinol SCHEMBL5800680 | 0.81 | XDH (0.66) | XDHTYMPGSK3BBACE1JAK2 | |
| SCHEMBL31495211 | 0.79 | XDH (0.66) | XDHJAK2JAK1TYK2JAK3 | |
| SCHEMBL31495212 | 0.79 | XDH (0.66) | XDHJAK2JAK1TYK2JAK3 | |
| SCHEMBL30624835 | 0.74 | XDH (0.58) | XDHALDH1A1MAPTHPGDSMN1; SMN2 | |
| SCHEMBL1719732 | 0.74 | XDH (0.58) | XDHALDH1A1MAPTHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4192 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4681719-A2 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | XORTX Therapeutics Inc. (CA) | 2026-01-21 | — | — | EP | claimed |
| US-20250270302-A1 | ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS SPECIFICALLY BINDING TO GREMLIN-1 AND USES THEREOF | KANTONSSPITAL ST. GALLEN (CH) | 2025-08-28 | — | — | US | claimed |
| US-20250257123-A1 | ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS PAN-SPECIFICALLY BINDING TO GREMLIN-1 AND GREMLIN-2 AND USES THEREOF | KANTONSSPITAL ST. GALLEN (CH) | 2025-08-14 | — | — | US | claimed |
| WO-2025125896-A2 | ASSEMBLING AND DENSIFYING ACTIVATED CARBON RAW MATERIALS FOR GRANULAR ACTIVATED CARBON WITH ENHANCED UNIFORMITY AND ADSORPTIVE PROPERTIES | ARQ IP LIMITED (GB) | 2025-06-19 | — | — | WO | claimed |
| EP-4568704-A1 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | XORTX Therapeutics Inc. (CA) | 2025-06-18 | — | — | EP | claimed |
| CN-120164249-A | Pedestrian gait recognition method under dense shielding condition | 中国科学院沈阳自动化研究所 | 2025-06-17 | — | — | CN | claimed |
| US-20250177348-A1 | Methods for Fructokinase Meditation of Alcohol Craving and Alcohol Induced Liver Disease | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2025-06-05 | — | — | US | claimed |
| WO-2025101968-A1 | TREATMENT OF NEURODEGENERATIVE DISEASES CAUSED BY REPEAT EXPANSION WITH NUCLEOSIDE ADMINISTRATION | REPEAT THERAPEUTICS, INC. (US) | 2025-05-15 | — | — | WO | claimed |
| CN-119985745-A | Detection method for micromolecular phenolic substances and application thereof | 北京中医药大学 | 2025-05-13 | — | — | CN | claimed |
| WO-2025096655-A1 | SYSTEMS AND METHODS FOR MANUFACTURING ELECTROCHROMICS | KENNESAW STATE UNIVERSITY RESEARCH AND SERVICE FOUNDATION, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| EP-0237348-B1 | CELL PROTECTION | THE WELLCOME FOUNDATION LIMITED (GB) | 1990-09-05 | — | — | EP | claimed |
| WO-1990006115-A2 | PREPARATIONS OF OXYPURINOL AND/OR ITS ALKALI OR ALKALINE EARTH SALTS | HENNING BERLIN GMBH CHEMIE- UND PHARMAWERK (DE) | 1990-06-14 | — | — | WO | claimed |
| WO-1990006116-A2 | AGENTS FOR TREATING CHRONIC INFLAMMATORY DISEASES OF THE INTESTINES | HENNING BERLIN GMBH CHEMIE- UND PHARMAWERK (DE) | 1990-06-14 | — | — | WO | claimed |
| US-4871742-A | ADMINISTERING ALLOPURINOL, OXYPURINOL, OR FLAVONOID | LABORATORIES CHAUVIN (FR) | 1989-10-03 | — | — | US | claimed |
| EP-0239289-A1 | Novel pharmaceutical combinations | THE WELLCOME FOUNDATION LIMITED (GB) | 1987-09-30 | — | — | EP | claimed |
| EP-0237348-A1 | Cell protection | THE WELLCOME FOUNDATION LIMITED (GB) | 1987-09-16 | — | — | EP | claimed |
| EP-0148883-A1 | ALLOPURINOL PRODRUGS. | GEA AS (DK) | 1985-07-24 | — | — | EP | claimed |
| WO-1985000368-A1 | ALLOPURINOL PRODRUGS | A/S GEA (DK) | 1985-01-31 | — | — | WO | claimed |
| EP-0004621-B1 | PROCESS FOR THE MULTI-STEP PREPARATION OF ZEAXANTHINE AND ALLOXANTHINE STARTING FROM DERIVATIVES OF CYCLOHEXANON AND CYCLOHEXANOL; DERIVATIVES OF CYCLOHEXANON AND CYCLOHEXANOL | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1984-05-09 | — | — | EP | claimed |
| EP-0004621-A2 | Process for the multi-step preparation of zeaxanthine and alloxanthine starting from derivatives of cyclohexanon and cyclohexanol; derivatives of cyclohexanon and cyclohexanol | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1979-10-17 | — | — | EP | claimed |